Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

Joan Schiller, Dominic Tilden, Michael Aristides, Michael Lees, Adrian Kielhorn, Nikos Maniadakis, Shkun Bhalla

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe'. Together they form a unique fingerprint.

Medicine & Life Sciences